Given the assumption that moderately high prolactin levels would counteract insulin resistance and glucose intolerance [9], patients with lower baseline prolactin levels seem to be those who are incapable of a beneficial endocrine reaction to their abnormal metabolic status. This evidence concerns the gene PRL and Insulin resistance.